Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Fang, Hui
RECAM, NCT04807348: Chiglitazar Added to Metformin for Type 2 Diabetes	Completed	3	533	RoW	Chiglitazar 32mg, Bilessglu, CS038, Chiglitazar 48mg, Placebo, Chiglitazar simulator, Metformin Hydrochloride, Glucophage	Chipscreen Biosciences, Ltd.	Type 2 Diabetes	02/23	02/23
NCT06738979: A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese Subjects	Not yet recruiting	3	408	RoW	TQF3510 (Semaglutide Injection), Wegovy®	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Obesity	07/26	08/26